Analysts and investors alike are anticipating what the future holds for Microbiome-focused company Synthetic Biologics Inc (NYSEMKT:SYN) and biotechnology company Heron Therapeutics Inc (NASDAQ:HRTX) as …
In a research report published today, BTIG analyst Tim Chiang reiterated a Buy rating on shares of Synthetic Biologics Inc (NYSEMKT:SYN) with a price …
Synthetic Biologics Inc (NYSEMKT:SYN), a clinical-stage company focused on developing therapeutics to protect the microbiome while targeting pathogen-specific diseases, presented data from its …
In a research report published Tuesday, BTIG analyst Tim Chiang initiated coverage on shares of Synthetic Biologics Inc (NYSEMKT:SYN) with a Buy rating and a $5.00 price …
In a research report issued yesterday, Griffin analyst Keith Markey reiterated a Buy rating on shares of Synthetic Biologics Inc (NYSEMKT:SYN) and raised the price …
Synthetic Biologics Inc (NYSEMKT:SYN), a clinical-stage company focused on developing therapeutics to protect the microbiome while targeting pathogen-specific diseases, reported financial results for …
Synthetic Biologics Inc (NYSEMKT:SYN), a clinical-stage company focused on developing therapeutics to protect the microbiome while targeting pathogen-specific diseases, today announced that it has …
Netflix, Inc. (NASDAQ:NFLX) shot up more than 10% in pre-market trading to $108.
